Related Experiment Video
Updated: Oct 16, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression
1Departments of Surgical Oncology/Molecular and Cellular Oncology and the Breast Cancer Research Program, the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
14-3-3 sigma, implicated in cell cycle arrest by p53, was cloned by expression cloning through cyclin-dependent kinase 2 (CDK2) association. 14-3-3 sigma shares cyclin-CDK2 binding motifs with different cell cycle regulators, including p107, p130, p21(CIP1), p27(KIP1), and p57(KIP2), and is associated with cyclin.CDK complexes in vitro and in vivo. Overexpression of 14-3-3 sigma obstructs cell cycle entry by inhibiting cyclin-CDK activity in many breast cancer cell lines. Overexpression of 14-3-3 sigma can also inhibit cell proliferation and prevent anchorage-independent growth of these cell lines. These findings define 14-3-3 sigma as a negative regulator of the cell cycle progression and suggest that it has an important function in preventing breast tumor cell growth.
Insights
14-3-3 sigma protein, a cell cycle regulator, was identified through its association with cyclin-dependent kinase 2 (CDK2). Its overexpression inhibits cell cycle progression and proliferation, suggesting a role in preventing breast tumor growth.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- 14-3-3 sigma is involved in p53-mediated cell cycle arrest.
- It shares binding motifs with known cell cycle regulators.
Purpose of the Study:
- To clone 14-3-3 sigma using expression cloning.
- To investigate its role in cell cycle regulation and breast cancer.
Main Methods:
- Expression cloning based on cyclin-dependent kinase 2 (CDK2) association.
- In vitro and in vivo association studies with cyclin-CDK complexes.
- Overexpression studies in breast cancer cell lines.
Main Results:
- 14-3-3 sigma was cloned via CDK2 association.
- It associates with cyclin-CDK complexes.
- Overexpression inhibits cyclin-CDK activity, cell cycle entry, proliferation, and anchorage-independent growth in breast cancer cells.
Conclusions:
- 14-3-3 sigma acts as a negative regulator of cell cycle progression.
- It plays a significant role in inhibiting breast tumor cell growth.
Related Concept Videos
Positive Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

